Strict glycemic control reduces EuroSCORE expected mortality in diabetic patients undergoing myocardial revascularization

被引:54
作者
D'Alessandro, Cosimo
Leprince, Pascal
Golmard, Jean Louis
Ouattara, Alexandre
Aubert, Stephane
Pavie, Alain
Gandjbakhch, Iradj
Bonnet, Nicolas
机构
[1] Hop La Pitie Salpetriere, Div Thorac & Cardiovasc, Inst Cardiol, F-75651 Paris 13, France
[2] Hop La Pitie Salpetriere, Dept Anesthesia & Crit Care, F-75651 Paris, France
[3] Univ Paris 06, Dept Biostat, Ctr Hosp Univ Pitie Salpetriere, Assistance Publ Hop Paris, F-75651 Paris 13, France
[4] Hop La Pitie Salpetriere, Dept Biostat, F-75651 Paris 13, France
关键词
D O I
10.1016/j.jtcvs.2007.02.028
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We sought to evaluate the effect of a strict glycemic control protocol on a series of diabetic patients undergoing surgical myocardial revascularization. Methods: Between January 2003 and June 2004, 300 diabetic patients undergoing myocardial revascularization received a local protocol of insulin administration (protocol, group P). Patients were divided into 2 risk classes, according to their additive EuroSCORE value: low-moderate risk (0-4) and moderate-high risk (>4). The logistic EuroSCORE algorithm was used to calculate the expected probability of death. A control group was selected, including a series of 300 consecutive diabetic patients (no protocol group, group NP) who underwent coronary artery bypass grafting between March 2001 and September 2002, just before the introduction of the protocol. A propensity analysis was performed to control for selection bias. Results: Both groups showed similar EuroSCORE risk profiles: mean additive and logistic EuroSCORE values were 4.16 and 4.29 in group P versus 3.93 and 3.91 in group NP. Observed and expected mortalities of group P were 0.6% versus 1.8% (low-moderate risk), 2.5% versus 8.0% (moderate-high risk, P = .03), and 1.3% versus 4.3% (entire group, P = .01). Observed and expected mortalities of group NP were 1.6% versus 1.9% (low-moderate risk), 8.3% versus 7.5% (moderate-high risk), and 4.0% versus 3.9% (entire group). Logistic regression confirmed observed mortality in group P to be significantly lower than the expected logistic EuroSCORE mortality. After risk adjustment, the protocol allowed us to reduce the mortality odds by 72% (odds ratio, 0.282; 95% confidence interval, 0.092-0.859; P < .03). Subgroup analysis for moderate-to high-risk patients showed the protocol to improve mortality (odds ratio, 0.24; P < .05), whereas no significant improvement was found in low- to moderate-risk patients. Addition of the propensity score to the multivariable analysis did not significantly displace P values and odds ratios. Sensitivity analysis of patients who underwent coronary artery bypass grafting without additional procedures showed the protocol to maintain its protective effect (odds ratio, 0.15; P < .05). Conclusion: Optimal glucose control highly reduces EuroSCORE expected mortality in diabetic patients undergoing myocardial revascularization, especially in moderate-to high-risk patients.
引用
收藏
页码:29 / 37
页数:9
相关论文
共 35 条
[1]   Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty [J].
Barsness, GW ;
Peterson, ED ;
Ohman, EM ;
Nelson, CL ;
DeLong, ER ;
Reves, JG ;
Smith, PK ;
Anderson, RD ;
Jones, RH ;
Mark, DB ;
Califf, RM .
CIRCULATION, 1997, 96 (08) :2551-2556
[2]   Comparing apples and oranges [J].
Blackstone, EH .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2002, 123 (01) :8-15
[3]  
BONOW RO, 2004, AM J MED S5A, V116
[4]   Deep sternal wound infection: Risk factors and outcomes [J].
Borger, MA ;
Rao, V ;
Weisel, RD ;
Ivanov, J ;
Cohen, G ;
Scully, HE ;
David, TE .
ANNALS OF THORACIC SURGERY, 1998, 65 (04) :1050-1056
[5]   Effect of diabetes on-early and late survival after isolated first coronary bypass surgery in multivessel disease [J].
Calafiore, AM ;
Di Mauro, M ;
Di Giammarco, G ;
Contini, M ;
Vitolla, G ;
Iacò, AL ;
Canosa, C ;
D'Alessandro, S .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (01) :144-154
[6]   Maintenance of normoglycemia during cardiac surgery [J].
Carvalho, G ;
Moore, A ;
Qizilbash, B ;
Lachapelle, K ;
Schricker, T .
ANESTHESIA AND ANALGESIA, 2004, 99 (02) :319-324
[7]   Attempting to maintain normoglycemia during cardiopulmonary bypass with insulin may initiate postoperative hypoglycemia [J].
Chaney, MA ;
Nikolov, MP ;
Blakeman, BP ;
Bakhos, M .
ANESTHESIA AND ANALGESIA, 1999, 89 (05) :1091-1095
[8]  
D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO
[9]  
2-B
[10]   Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery [J].
Doenst, T ;
Wijeysundera, D ;
Karkouti, K ;
Zechner, C ;
Maganti, M ;
Rao, V ;
Borger, MA .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 130 (04) :1144-1150